期刊文献+

甲磺酸瑞波西汀有关物质检测方法的比较 被引量:1

Comparison of Methods for Determination of Related Substances in Reboxetine Mesilate
下载PDF
导出
摘要 对甲磺酸瑞波西汀国家食品药品监督管理局标准有关物质的三种检测方法 YBH10432004(试行)、YBH02392008(试行)和YBH09872008进行了对比研究。结果表明,标准YBH10432004(试行)与YBH02392008(试行)检测出混合降解液中杂质个数为10个,主峰拖尾严重,柱效较低;标准YBH09872008检测出混合降解液中杂质个数为12个,主峰峰形对称性较好,柱效较高,与各杂质的分离度能满足要求。 The related substance detection methods of State Food and Drug Administration Standard (Trial) YBHI0432004, YBH02392008 and YBH09872008 for Reboxetine mesylate were compared. The results showed that ten impurities were detected in the mixed degradation solution by the Standard YBH10432004 and YBH02392008, with a training peak and low column efficiency. Twelve impurities were detected by the Standard YBH09872008, with a symmetrical peak and high column efficiency, and the separation of impurities met the requirements.
作者 李艳
出处 《广州化学》 CAS 2015年第4期67-70,共4页 Guangzhou Chemistry
关键词 甲磺酸瑞波西汀 有关物质 混合降解液 方法比较 Reboxetine mesylate related substances mixed degradation solution method comparison
  • 相关文献

参考文献4

  • 1张军,李文标,郭桂欣,翟屹民,果伟,王传跃.HPLC紫外检测法测定血浆甲磺酸瑞波西汀浓度[J].首都医科大学学报,2008,29(4):431-435. 被引量:2
  • 2国家食品药品监督管理局.国家药品标准:YBH10432004(试行)[S].北京:中国医药科技出版社,2004.
  • 3国家食品药品监督管理局.国家药品标准:YBH02392008(试行)[S].北京:中国医药科技出版社,2008.
  • 4国家食品药品监督管理局.国家药品标准:YBH09872008[S].北京:中国医药科技出版社.2008.

二级参考文献14

  • 1李文标,周蓓蕾,张军,王智民,果伟,翟屹民,王传跃.瑞波西汀在中国男性健康志愿者体内的药动学研究[J].中国新药杂志,2005,14(9):1174-1178. 被引量:5
  • 2朱运贵,刘晓磊.高效液相色谱-质谱法测定人体中瑞波西汀的药动学和生物利用度[J].中国新药与临床杂志,2006,25(8):583-586. 被引量:1
  • 3Kadhe N G, Chillar A J, Deshmukh Y A. Reboxetine: a novel antidepressant [ J ]. J Postgrad Med, 2003,49 : 373- 375.
  • 4Delgado P L, Michaels T. Reboxitine: a review of efficacy and tolerability[ J]. Drugs of Today, 1999,35:725-737.
  • 5Tanum L. Reboxitine: tolerability and safety profile in patients with major depression [ J ]. Acta Psychiatr Scand, 2000,101 ( suppl. 402) :37-40.
  • 6Rubio G, San L, Lopez-Munoz F, et al. Reboxetine adjunct for partial or nonresponders to antidepressant treatment [ J]. J Affective Disord, 2004,81:67-72.
  • 7Edwards D M, Pellizzoni C, Breuel H P, et al. Pharmacokinetics of reboxetine in healthy volunteers: single oral doses, linearity and plasma protein binding [ J ]. Biopharm Drug Dispos, 1995,16:443-460.
  • 8Ohman D, Norlander B, Peterson C, et al. Bioanalysis of racemic reboxetine and its desethylated metabolite in a therapeutic drug monitoring setting using solid phase extraction and HPLC[ J]. Ther Drug Monit, 2001,23:27-34.
  • 9Raggi M A, Mandrioli R, Casamenti G, et al. Determination of reboxetine, a recent antidepressant drug, in human plasma by means of two high-performance liquid chromatography methods [ J ]. J Chromatogr A, 2002,949:23-33.
  • 10Frigerio F E, Pianezzola E, Strolin B M. Sensitive procedure for the determination of reboxetine enantiomers in human plasma by reversed-phase high-performance liquid chromatography with fluorimetrie detection after ehiral derivatization with ( + )-1-( 9-fluorenyl ) ethyl ehloroformate [J]. J Chromatogr A, 1994,660:351-358.

共引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部